Ignite Creation Date:
2024-07-17 @ 12:00 PM
Last Modification Date:
2024-10-26 @ 3:32 PM
Study NCT ID:
NCT06462183
Status:
RECRUITING
Last Update Posted:
2024-07-01
First Post:
2024-06-07
Brief Title:
Study of Safety and Efficacy of RGT-61159 in Adults With RelapsedRefractory Adenoid Cystic Carcinoma ACC or Colorectal Carcinoma CRC
Sponsor:
Rgenta Therapeutics Inc
Organization:
Rgenta Therapeutics Inc
Key Dates - Follows AllAPIJSON File Order
Start Date:
2024-06
Start Date Type:
ESTIMATED
Primary Completion Date:
2025-12
Primary Completion Date Type:
ESTIMATED
Completion Date:
2027-06
Completion Date Type:
ESTIMATED
First Submit Date:
2024-06-07
First Submit QC Date:
None
Study First Post Date:
2024-06-17
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2024-10-14
Last Update Post Date:
2024-07-01
Last Update Post Date Type:
ACTUAL